Ferndale Pharma Group
Private Company
Funding information not available
Overview
Ferndale Pharma Group is a well-established, multi-faceted healthcare organization with a strong commercial footprint. Its business is structured into distinct operating units: Eloquest Healthcare targets hospital-acquired infection prevention; Ferndale Healthcare and Ferndale UK focus on dermatology and topical therapeutic markets; and Ferndale Contract Manufacturing provides CDMO services. With a long operational history and a diversified model spanning proprietary products and services, the company is positioned as a stable, revenue-generating entity in the specialty pharma and topical drug sectors.
Technology Platform
Vertically integrated expertise in the development, formulation, and manufacturing of topical pharmaceuticals (creams, ointments, gels). Capabilities span from product development through commercial-scale manufacturing and quality control.
Opportunities
Risk Factors
Competitive Landscape
In dermatology, Ferndale competes with large pharma companies (e.g., AbbVie, Pfizer) and pure-play dermatology firms (e.g., Bausch Health's dermatology unit, Ortho Dermatologics). In infection prevention, it competes with larger medtech and pharmaceutical companies. Its CDMO division competes with other topical-focused manufacturers and larger, full-service CDMOs.